Clinical Trial: Phase I/II Clinical Trials of SHR-8203 Injection in Participants With Advanced Solid Tumors

U.S., Aug. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07769242) titled 'Phase I/II Clinical Trials of SHR-8203 Injection in Participants With Advanced Solid Tumors' on Aug. 12.

Brief Summary: This trial is a multicenter, open-label Phase I/II clinical study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, and efficacy of SHR-8203 injection in participants with advanced solid tumors.

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: Solid Tumors

Intervention: DRUG: SHR-8203 Injection

SHR-8203 Injection Dose 1/ Dose 2/ Dose 3/ Dose 4

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd...